Author: Pipeline Rx

“Youscript has advanced software that analyzes how patients taking multiple medications may be at risk due to the combination of the meds they are taking,” Brian Roberts, CEO of PipelineRx told Healthcare Purchasing News.“Most of the tools today measure drug to drug interaction not the impact created by the combination of medications – impact could include adverse drug events, re-hospitalization or could impact the clinical effectiveness of the medications. This service benefits the hospital or payer who would be financially responsible for the re-admittance and/or the cost of ineffective medications.”

CGH Medical Center partners with PipelineRx for their Patient Discharge Solution, which provides a workflow to help pharmacists engage with patients at and following discharge. Based on their clinical skillset and deep understanding of comprehensive medication management, pharmacists are the ideal providers to counsel patients on their medications before they leave the hospital.

Hilton Beachfront Resort, Santa Barbara, July 15-17, 2019 Attending the Telehealth Innovation Forum?  Come meet our CEO Brian Roberts at the Experience Zone and get a demo of our newest Patient Discharge Solution. Schedule a Demo

Friday, May 17, 2019, 2:00-3:00 pm EDT The  2019 series of continuing education webinars for pharmacists and pharmacy technicians. Presented by PipelineRx and Carilion Clinics. This presentation will focus on venous thromboembolism (VTE) treatment in oncology patients. Primary literature will be evaluated in a chronological

Wednesday, May 1, 2019, 2:00-3:00 pm EST Continuing education webinars for pharmacists and pharmacy technicians. Presented by PipelineRx and Carilion Clinic. This continuing education presentation is a review of heparin-induced thrombocytopenia (HIT) including pathophysiology and complications.

Friday, April 19, 2019, 2:00-3:00 pm EST Continuing education webinars for pharmacists and pharmacy technicians. Presented by PipelineRx and Carilion Clinic. This continuing education presentation discusses the significance, adverse effects, physiologic changes, and pharmacokinetic/pharmacodynamic medication changes associated with targeted temperature management.